If I didn't had to continually respond to clueless investors like you and continually correct their post then my post count wouldn't be that high. Again, that's what you don't get, IMU weren't desperate for funding for another 6 months unlike that shit stock of yours you keep ramping which somehow has a MC of $100M but only cash of $1.25M with "revenue" of $282K and spend $2M in salary and administration and corporate expenditure. I told you 5 years ago, Wheezo is a shit product and won't be commercially viable and you ignored me. Honestly, you should just take profit and invest in IMU given how cheap the shares are right now but you do you as that stock desperately need another CR again this quarter for just the $2M salary and administration and corporate expenditure.
Yes, CN are bad financing if that's the only funding a company has available for their operation expense as they are done at a massive discount for the note holders to sell. It isn't arrange like that for IMU as they are at a premium depending on clinical trial updates in the next 2-5 months which are already long awaited, IMU still has $46M in cash without the $45M in total R&D rebate and $20M in CN which is at a premium for 5 months and $26M in warrants exercisable at 5c.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)